Posts from this topic will be added to your daily email digest and your homepage feed. Finnish startup Donut Lab claims it’s made a solid-state battery breakthrough. Whether you believe it or not, the ...

Physical media fans, this is a preorder well worth picking up for your collection: Monty Python and the Holy Grail is getting a 50th anniversary 4K steelbook (see here at Amazon). Huzzah! The beloved ...

Jay-Z defended himself against anti-capitalist criticism in a cover story for GQ. "I make art first and then I make sure that I'm compensated for my art," he said. The billionaire rapper said realism ...

Tainted Grail: The Fall of Avalon released into its full version 1.0 update almost a year ago. Since then, the game has sold upwards of 250,000 copies and continues to provide some strong value, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company has burned through ...

Cancer test developer Grail (GRAL) has named Josh Ofman, the company's president, as its new chief executive officer, effective June 1, 2026, following the retirement of its long-serving CEO, Bob ...

Scientists may have spotted a long-sought triplet superconductor — a material that can transmit both electricity and electron spin with zero resistance. That ability could dramatically stabilize ...

Since scientists first discovered that human immune cells could be modified to become cancer-fighting agents, they’ve been trying to engineer a cell that’s effective against solid tumors, which ...

The biotech is developing a test to detect multiple cancers. However, a recent clinical trial did not produce the hoped-for results. The share price will likely remain low unless Grail has more ...

Grail's trial missed its primary endpoint, causing a major stock drop. Management is hoping follow-up data will prove more beneficial. 10 stocks we like better than Grail › Grail (NASDAQ: GRAL) stock ...

A large, three-year clinical trial designed to demonstrate how Grail’s blood test for early cancer detection could work in a broad population has preliminary results showing reduction in late-stage ...

Feb 20 (Reuters) - Grail's (GRAL.O), opens new tab shares plunged nearly 50% on Friday after the company said routine screening with its cancer blood test failed to significantly boost early detection ...